Open AccessTo evaluate the safety and efficacy of saroglitazar among pre-diabetes and dyslipidemia
International Journal Of Health SciencesPeer ReviewedPravin G. Dhone +32022Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support